Brainsway(BWAY) - 2022 Q4 - Annual Report

Business, Economic and Industry risks · Clinical trials involve a lengthy and expensive process with an uncertain outcome, which may delay or cause us to abandon the development of Deep TMS for additional indications. · We bare the risk of product liability lawsuits and warranty claims which we might harm our business, exceed our insurance policy coverage and we may not have enough funds to cover such claims or lawsuits damages. · The misuse or off-label use of Deep TMS may harm our reputation in the market ...